Biokinetics and Dosimetry of 177Lu-Pentixather

Heribert Hänscheid; Andreas Schirbel; Philipp Hartrampf; Sabrina Kraus; Rudolf A. Werner; Hermann Einsele; Hans-Jürgen Wester; Michael Lassmann; Martin Kortüm; Andreas K. Buck

doi:10.2967/jnumed.121.262295

Research ArticleClinical Investigation

Biokinetics and Dosimetry of ¹⁷⁷Lu-Pentixather

Heribert Hänscheid, Andreas Schirbel, Philipp Hartrampf, Sabrina Kraus, Rudolf A. Werner, Hermann Einsele, Hans-Jürgen Wester, Michael Lassmann, Martin Kortüm and Andreas K. Buck

Journal of Nuclear Medicine May 2022, 63 (5) 754-760; DOI: https://doi.org/10.2967/jnumed.121.262295

Heribert Hänscheid

1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andreas Schirbel

1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philipp Hartrampf

1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sabrina Kraus

2Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rudolf A. Werner

1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hermann Einsele

2Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hans-Jürgen Wester

3Department of Pharmaceutical Radiochemistry, TU Munich, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Lassmann

1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin Kortüm

2Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andreas K. Buck

1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Article Information

vol. 63 no. 5 754-760

DOI

https://doi.org/10.2967/jnumed.121.262295

PubMed

34413147

Published By

Society of Nuclear Medicine

Print ISSN

0161-5505

Online ISSN

2159-662X

History

Received for publication March 15, 2021
Revision received August 5, 2021
Published online April 28, 2022.

Article Versions

previous version (August 19, 2021 - 09:49).
You are viewing the most recent version of this article.

Author Information

Heribert Hänscheid¹,
Andreas Schirbel¹,
Philipp Hartrampf¹,
Sabrina Kraus²,
Rudolf A. Werner¹,
Hermann Einsele²,
Hans-Jürgen Wester³,
Michael Lassmann¹,
Martin Kortüm² and
Andreas K. Buck¹

¹Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
²Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; and
³Department of Pharmaceutical Radiochemistry, TU Munich, Munich, Germany

For correspondence or reprints, contact Heribert Hänscheid (haenscheid_h{at}ukw.de).

View Full Text

Statistics from Altmetric.com

Cited By...

1 Citations
13 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

CXCR4-targeted theranostics in oncology

Andreas K. Buck, Sebastian E. Serfling, Thomas Lindner, Heribert Hänscheid, Andreas Schirbel, Stefanie Hahner, Martin Fassnacht, Hermann Einsele, Rudolf A. Werner

European Journal of Nuclear Medicine and Molecular Imaging 2022 49 12
C-X-C Motif Chemokine Receptor 4–Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma

Andreas K. Buck, Götz Ulrich Grigoleit, Sabrina Kraus, Andreas Schirbel, Michael Heinsch, Niklas Dreher, Takahiro Higuchi, Constantin Lapa, Heribert Hänscheid, Samuel Samnick, Hermann Einsele, Sebastian E. Serfling, Rudolf A. Werner

Journal of Nuclear Medicine 2023 64 1
Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine

Circe D. van der Heide, Simone U. Dalm

European Journal of Nuclear Medicine and Molecular Imaging 2022 49 13
Theranostics in Hematooncology

Andreas K. Buck, Sebastian E. Serfling, Sabrina Kraus, Samuel Samnick, Niklas Dreher, Takahiro Higuchi, Leo Rasche, Hermann Einsele, Rudolf A. Werner

Journal of Nuclear Medicine 2023 64 7
68Ga-Labeled Cystine Knot Peptide Targeting Integrin αvβ6 for Lung Cancer PET Imaging

Jingyun Ren, Shiyu Zhu, Guojin Zhang, Xiaoyue Tan, Ling Qiu, Jianguo Lin, Lei Jiang

Molecular Pharmaceutics 2022 19 7
CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors

Ingo Hartlapp, Philipp E. Hartrampf, Sebastian E. Serfling, Vanessa Wild, Alexander Weich, Leo Rasche, Sabine Roth, Andreas Rosenwald, Patrick W. Mihatsch, Anne Hendricks, Armin Wiegering, Verena Wiegering, Heribert Hänscheid, Andreas Schirbel, Rudolf A. Werner, Andreas K. Buck, Hans-Jürgen Wester, Hermann Einsele, Volker Kunzmann, Constantin Lapa, K. Martin Kortüm

Journal of Nuclear Medicine 2023 64 9
Theranostika in der Nuklearmedizin

Ann-Christin Eder, Matthias Eder

Der Onkologe 2022 28 2
Detecting CXCR4 Expression in Meningioma on68Ga-Pentixafor PET/MRI

Simone Krebs, Jazmin Schwartz, Christian Grommes, Robert J. Young, Heiko Schöder, Marius E. Mayerhoefer

Journal of Nuclear Medicine 2023 64 4
Radiopharmaceutical Therapy

Andreas K. Buck, Heribert Hänscheid, Sebastian E. Serfling, Takahiro Higuchi, Leo Rasche, Hermann Einsele, Rudolf A. Werner

2023
Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging

Muriel Aline Spahn, Kaat Luyten, Tom Van Loy, Mike Sathekge, Christophe M. Deroose, Michel Koole, Dominique Schols, Wim Vanduffel, Kristof De Vos, Pieter Annaert, Guy Bormans, Frederik Cleeren

Nuclear Medicine and Biology 2024 132-133

Article usage

Article usage: August 2021 to August 2024

	Abstract	Full	Pdf
Aug 2021	519	0	33
Sep 2021	358	0	22
Oct 2021	731	0	28
Nov 2021	259	0	29
Dec 2021	255	0	24
Jan 2022	192	0	21
Feb 2022	199	0	27
Mar 2022	138	0	91
Apr 2022	192	61	81
May 2022	401	417	133
Jun 2022	245	224	63
Jul 2022	495	23	39
Aug 2022	268	18	19
Sep 2022	466	6	36
Oct 2022	326	29	41
Nov 2022	47	102	29
Dec 2022	41	396	32
Jan 2023	45	401	41
Feb 2023	16	367	41
Mar 2023	21	387	51
Apr 2023	18	300	29
May 2023	16	157	29
Jun 2023	18	213	41
Jul 2023	31	284	38
Aug 2023	27	336	33
Sep 2023	24	292	38
Oct 2023	24	129	38
Nov 2023	21	166	28
Dec 2023	39	92	47
Jan 2024	34	237	45
Feb 2024	14	239	31
Mar 2024	19	161	54
Apr 2024	21	151	61
May 2024	9	84	37
Jun 2024	25	98	38
Jul 2024	51	182	44
Aug 2024	51	138	448

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 63, Issue 5

May 1, 2022

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Biokinetics and Dosimetry of 177Lu-Pentixather

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Biokinetics and Dosimetry of ¹⁷⁷Lu-Pentixather

Heribert Hänscheid, Andreas Schirbel, Philipp Hartrampf, Sabrina Kraus, Rudolf A. Werner, Hermann Einsele, Hans-Jürgen Wester, Michael Lassmann, Martin Kortüm, Andreas K. Buck

Journal of Nuclear Medicine May 2022, 63 (5) 754-760; DOI: 10.2967/jnumed.121.262295

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Biokinetics and Dosimetry of ¹⁷⁷Lu-Pentixather

Heribert Hänscheid, Andreas Schirbel, Philipp Hartrampf, Sabrina Kraus, Rudolf A. Werner, Hermann Einsele, Hans-Jürgen Wester, Michael Lassmann, Martin Kortüm, Andreas K. Buck

Journal of Nuclear Medicine May 2022, 63 (5) 754-760; DOI: 10.2967/jnumed.121.262295

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors
Theranostics in Hematooncology
Detecting CXCR4 Expression in Meningioma on 68Ga-Pentixafor PET/MRI
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma

Google Scholar

Keywords

pentixather
biokinetics
dosimetry
CXCR4
endoradiotherapy

Main menu

User menu

Search

Biokinetics and Dosimetry of ¹⁷⁷Lu-Pentixather

Article Information

Article Versions

Author Information

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: August 2021 to August 2024

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords